New pill shows promise for severe eczema in early trial
Disease control
Ongoing
This study tests an experimental tablet called HSK44459 in 150 adults with moderate-to-severe atopic dermatitis (eczema). The goal is to see if the drug can reduce skin redness, itching, and rash over 12 weeks compared to a placebo. Participants must have had eczema for at least …
Phase: PHASE2 • Sponsor: Xizang Haisco Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 04, 2026 16:18 UTC